Literature DB >> 18432971

Induction and measurement of cytotoxic T lymphocyte activity.

John Wonderlich1, Gene Shearer, Alexandra Livingstone, Andrew Brooks.   

Abstract

Cytotoxic T lymphocytes (CTL) kill target cells on the basis of cell-surface antigen recognition and are important in the host response to tumors, transplants, and viruses. This unit presents several protocols for generating and measuring CTL activity. The first describes generating CTL against some of the most commonly used target antigens. Two methods for the quantitation of CTL activity are described based on the two pathways used bt CTL to kill target cells. In one pathway, they release lytic granules containing perforin and granzymes, leading to apoptosis and target cell lysis. In a second pathway, they trigger apoptosis via Fas/Fas ligand interactions. In the chromium-release assay provided here, labeled antigenic targets are recognized and lysed, releasing radioactivity into the supernatant. In the JAM test protocol, CTL activity is determined by measuring degradation of radioactively labeled DNA in target cells that have undergone apoptotic cell death. Rather than measuring release of radioactivity, the JAM test measures the amount of DNA retained in target cells that are not killed by CTL. Two support protocols detail the generation of CTL precursors (CTLp) against antigens that require priming in vivo. A second set of support protocols describe the preparation of both stimulator and target cells for these responses using two representative antigens, trinitrophenyl and viruses. Finally, two alternate protocols illustrate how to determine total CTLp activity in a population that might express cytolytic activity. These protocols bypass MHC restriction and the original antigen specificity of CTLp by polyclonal stimulation of CTLp with mitogens followed by attachment of CTL to target cells and subsequent cytolysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18432971     DOI: 10.1002/0471142735.im0311s72

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  18 in total

1.  Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.

Authors:  Violeta Romero; Justyna Fert-Bober; Peter A Nigrovic; Erika Darrah; Uzma J Haque; David M Lee; Jennifer van Eyk; Antony Rosen; Felipe Andrade
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

2.  Whole-animal imaging and flow cytometric techniques for analysis of antigen-specific CD8+ T cell responses after nanoparticle vaccination.

Authors:  Lukasz J Ochyl; James J Moon
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

3.  STAT2 Is Required for TLR-Induced Murine Dendritic Cell Activation and Cross-Presentation.

Authors:  Jun Xu; Michael H Lee; Marita Chakhtoura; Benjamin L Green; Kevin P Kotredes; Robert W Chain; Uma Sriram; Ana M Gamero; Stefania Gallucci
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

4.  Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.

Authors:  Vinod Singh; Qingyong Ji; Lionel Feigenbaum; Robert M Leighty; Arthur A Hurwitz
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

Review 5.  Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.

Authors:  Fadi Saade; Stacey Ann Gorski; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

6.  Low-level laser reduces the production of TNF-α, IFN-γ, and IL-10 induced by OVA.

Authors:  Rodrigo G Oliveira; Ana P Ferreira; Andréa J Côrtes; Beatriz J Vieira Aarestrup; Luis C Andrade; Fernando M Aarestrup
Journal:  Lasers Med Sci       Date:  2013-01-22       Impact factor: 3.161

7.  Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.

Authors:  Yong-Chen Lu; Xin Yao; Yong F Li; Mona El-Gamil; Mark E Dudley; James C Yang; Jorge R Almeida; Daniel C Douek; Yardena Samuels; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

8.  CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.

Authors:  Janet Chang; Peter Eggenhuizen; Kim M O'Sullivan; Maliha A Alikhan; Stephen R Holdsworth; Joshua D Ooi; A Richard Kitching
Journal:  J Am Soc Nephrol       Date:  2016-06-10       Impact factor: 10.121

9.  Progressive decline of T and B cell numbers and function in a patient with CDC42 deficiency.

Authors:  Paria Kashani; Ashish Marwaha; Stephen Feanny; Vy Hong-Diep Kim; Adelle R Atkinson; Matilde Leon-Ponte; Roberto Mendoza-Londono; Eyal Grunebaum
Journal:  Immunol Res       Date:  2021-01-06       Impact factor: 2.829

10.  In vivo elimination of MHC-I-deficient lymphocytes by activated natural killer cells is independent of granzymes A and B.

Authors:  Matthias Regner; Lisa Pavlinovic; Nicolie Young; Arno Müllbacher
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.